Please assess the completion status of the following clinical trial:

Trial Title: In-exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Chest CT scan confirmation of bronchiectasis~* At least two exacerbations in the preceding 12 months requiring antibiotics~Exclusion Criteria:~* Cystic fibrosis~* Bullous emphysema~* History of spontaneous pneumothorax~* History of massive hemoptysis: greater than 200 cc in a 24 hour period~* Lung resection surgery in the past 6 months~* Use of the mechanical cough in-exsufflator in the prior 3 months~* Inability to speak and read English~* Inability to demonstrate proper use of the cough-assist or flutter device~* Unable to provide informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Assignment to In-Exsufflator Cough Assist Device (Type: ACTIVE_COMPARATOR): In-Exsufflator Cough Assist Device augments the expiratory flow and force of the patient's cough with the addition of a cycle of positive and negative inspiratory pressure when used daily
- Assignment to flutter valve device (Type: ACTIVE_COMPARATOR): flutter valve device delivers expiratory low-pressure vibratory pulse to the patient's airway when used daily

Based on this trial design, predict the completion outcome and termination type (if applicable).